glp-1 receptor agonists cardiovascular benefits and drawbacks of agonist use. Abbreviations: GLP-1 receptor agonists and myocardial
Description
Nonetheless, the mechanism underlying the effects of GLP-1RAs in the cardiovascular system remain unclear
M., Lehto, S., Ronnemaa, T., Pyorala, K
A variety of GLP-1RAs agents are currently available, including exenatide, liraglutide, dulaglutide, albiglutide, lixisenatide, semaglutide, and the dual GLP-1/GIP receptor agonist, tirzepatide
Ognard J, El Hajj G, Ghozy S et al (2025) Quality of life in patients with spontaneous intracranial hypotension: A systematic review and meta-analysis
